News
QDEL
28.80
-1.40%
-0.41
QuidelOrtho outlines $2.7B–$2.9B 2026 revenue target as company advances R&D pipeline and margin expansion
Seeking Alpha · 8h ago
QuidelOrtho (QDEL) Q4 2025 Earnings Transcript
The Motley Fool · 12h ago
QuidelOrtho ‘excited’ about new product launches in 2026
TipRanks · 12h ago
QuidelOrtho sees ‘typical’ flu season with 50M-55M annual market tests
TipRanks · 13h ago
QuidelOrtho sees FY26 CapEx $150M-$170M
TipRanks · 13h ago
QuidelOrtho provides FY26 segment guidance
TipRanks · 13h ago
QuidelOrtho sees FY26 adjusted EBITDA $630M-$670M
TipRanks · 13h ago
QuidelOrtho Q4 results beat on both lines, but issues weak 2026 EPS guidance
Seeking Alpha · 14h ago
*QuidelOrtho: Sees FY26 Adj EPS $2-Adj EPS $2.42 >QDEL
Dow Jones · 14h ago
*QuidelOrtho: CFO Joseph M. Busky Has Decided to Retire, Effective June 30, Co Has Begun a Search for Successor >QDEL
Dow Jones · 14h ago
Earnings Summary: QuidelOrtho Q4
Benzinga · 14h ago
QuidelOrtho announces CFO retirement and transition
TipRanks · 14h ago
QuidelOrtho Q4 2025 net loss at USD 131 million with 41% margin
Reuters · 14h ago
QUIDELORTHO OUTLOOK FY ADJUSTED EPS USD 2-2.42
Reuters · 14h ago
QUIDELORTHO CORP - CFO JOSEPH M. BUSKY TO RETIRE EFFECTIVE JUNE 30, 2026
Reuters · 14h ago
*QuidelOrtho 4Q Loss/Shr $1.92 >QDEL
Dow Jones · 14h ago
*QuidelOrtho 4Q Loss $130.7M >QDEL
Dow Jones · 14h ago
*QuidelOrtho 4Q Rev $723.6M >QDEL
Dow Jones · 14h ago
QuidelOrtho (NASDAQ:QDEL) Exceeds Q4 CY2025 Expectations
Barchart · 19h ago
QuidelOrtho: Q4 Earnings Snapshot
Barchart · 20h ago
More
Webull provides a variety of real-time QDEL stock news. You can receive the latest news about Quidel through multiple platforms. This information may help you make smarter investment decisions.
About QDEL
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.